Immunoselection techniques in hematopoietic stem cell transplantation

被引：5
作者：
Pira, Giuseppina Li [1 ]
Biagini, Simone [1 ]
Cicchetti, Elisabetta [1 ]
Merli, Pietro [1 ]
Brescia, Letizia Pomponia [1 ]
Milano, Giuseppe Maria [1 ]
Montanari, Mauro [1 ]
机构：
[1] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol & Oncol, Unit Immunohematol & Transfus Med, Piazza St Onofrio 4, I-00165 Rome, Italy
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2016年 / 54卷 / 03期
关键词：
Hematopoietic stem cell; Graft-versus-host disease; Alloreactive cells; Opportunistic infections; Cell manipulation; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HIGH-DOSE THERAPY; TERM-FOLLOW-UP; ACUTE MYELOID-LEUKEMIA; NAIVE T-CELLS; FOLLICULAR LYMPHOMA; MULTIPLE-MYELOMA;
D O I：
10.1016/j.transci.2016.05.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：356 / 363
页数：8
相关论文
共 69 条
  • [61] Depletion of T-cell receptor alpha/beta and CD 19 positive cells from apheresis products with the CliniMACS device
    Schumm, Michael
    Lang, Peter
    Bethge, Wolfgang
    Faul, Christoph
    Feuchtinger, Tobias
    Pfeiffer, Matthias
    Vogel, Wichard
    Huppert, Volker
    Handgretinger, Rupert
    [J]. CYTOTHERAPY, 2013, 15 (10) : 1253 - 1258
  • [62] Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial
    Stewart, AK
    Vescio, R
    Schiller, G
    Ballester, O
    Noga, S
    Rugo, H
    Freytes, C
    Stadtmauer, E
    Tarantolo, S
    Sahebi, F
    Stiff, P
    Meharchard, J
    Schlossman, R
    Brown, R
    Tully, H
    Benyunes, M
    Jacobs, C
    Berenson, R
    White, M
    DiPersio, J
    Anderson, KC
    Berenson, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) : 3771 - 3779
  • [63] Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis
    Teschner, D.
    Distler, E.
    Wehler, D.
    Frey, M.
    Marandiuc, D.
    Langeveld, K.
    Theobald, M.
    Thomas, S.
    Herr, W.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 (01) : 138 - 144
  • [64] The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable
    Tiercy, J-M
    Nicoloso, G.
    Passweg, J.
    Schanz, U.
    Seger, R.
    Chalandon, Y.
    Heim, D.
    Guengoer, T.
    Schneider, P.
    Schwabe, R.
    Gratwohl, A.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 515 - 522
  • [65] Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies
    Triplett, B. M.
    Shook, D. R.
    Eldridge, P.
    Li, Y.
    Kang, G.
    Dallas, M.
    Hartford, C.
    Srinivasan, A.
    Chan, W. K.
    Suwannasaen, D.
    Inaba, H.
    Merchant, T. E.
    Pui, C-H
    Leung, W.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 (07) : 968 - 977
  • [66] Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma:: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34+ cell enrichment device
    van Heeckeren, WJ
    Vollweiler, J
    Fu, PF
    Cooper, BW
    Meyerson, H
    Lazarus, HM
    Simic, A
    Laughlin, MJ
    Gerson, SL
    Koç, ON
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (01) : 42 - 55
  • [67] Six-of-the-best: unique contributions of γδ T cells to immunology
    Vantourout, Pierre
    Hayday, Adrian
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (02) : 88 - 100
  • [68] Vescio R, 1999, BLOOD, V93, P1858
  • [69] Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
    Vickers, Mark A.
    Wilkie, Gwen M.
    Robinson, Nicolas
    Rivera, Nadja
    Haque, Tanzina
    Crawford, Dorothy H.
    Barry, Jacqueline
    Fraser, Neil
    Turner, David M.
    Robertson, Victoria
    Dyer, Phil
    Flanagan, Peter
    Newlands, Helen R.
    Campbell, John
    Turner, Marc L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (03) : 402 - 410
1234567